设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Elsevier电子期刊(50)
在“
Elsevier电子期刊
”中,
命中:
50
条,耗时:小于0.01 秒
在所有数据库中总计命中:
50
条
1.
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment
作者:
Robert Dufour
a
;
robert.dufour@ircm.qc.ca
;
Jean Bergeron
b
;
Daniel Gaudet
c
;
Robert Weiss
d
;
G. Kees Hovingh
e
;
Zhizhi Qing
f
;
Feng Yang
g
;
Matthew Andisik
g
;
Albert Torri
g
;
Robert Pordy
g
;
Daniel A. Gipe
g
关键词:
AE
;
adverse event
;
Apo
;
apolipoprotein
;
CVD
;
cardiovascular disease
;
HDL-C
;
high-density lipoprotein cholesterol
;
HeFH
;
heterozygous familial hypercholesterolemia
;
LDL-C
;
low-density lipoprotein cholesterol
;
Lp(a)
;
lipoprotein (a)
;
LLT
;
lipid-lowering therapy
;
MedDRA
;
Medical Dictionary for Regulatory Activities
;
MI
;
myocardial infarction
;
PCSK9
;
proprotein convertase subtilisin/kexin type 9
;
Q2W
;
every 2
;
weeks
;
Q4W
;
every 4
;
weeks
;
SD
;
standard deviation
;
TEAE
;
treatment-emergent adver
刊名:International Journal of Cardiology
出版年:2017
2.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies
作者:
Gavin Giovannoni
a
;
g.giovannoni@qmul.ac.uk" class="auth_mail" title="E-mail the corresponding author
;
Ludwig Kappos
b
;
ludwig.kappos@usb.ch" class="auth_mail" title="E-mail the corresponding author
;
Ralf Gold
c
;
Ralf.Gold@ruhr-uni-bochum.de" class="auth_mail" title="E-mail the corresponding author
;
Bhupendra O Khatri
d
;
bokhatri@aol.com" class="auth_mail" title="E-mail the corresponding author
;
Krzysztof Selmaj
e
;
kselmaj@afazja.am.lodz.pl" class="auth_mail" title="E-mail the corresponding author
;
Kimberly Umans
f
;
kim.umans@biogen.com" class="auth_mail" title="E-mail the corresponding author
;
Steven J Greenberg
g
;
steven.greenberg@abbvie.com" class="auth_mail" title="E-mail the corresponding author
;
Marianne Sweetser
f
;
1
;
msweetser@alnylam.com" class="auth_mail" title="E-mail the corresponding author
;
Jacob Elkins
f
;
jake.elkins@biogen.com" class="auth_mail" title="E-mail the corresponding author
;
Peter McCroskery
f
;
peter.mccroskery@biogen.com" class="auth_mail" title="E-mail the corresponding author
关键词:
AE
;
adverse event
;
ALT
;
alanine aminotransferase
;
AST
;
aspartate aminotransferase
;
DRESS
;
drug reaction with eosinophilia and systematic symptoms
;
DSMB
;
data safety monitoring board
;
GGT
;
gamma-glutamyl transferase
;
GI
;
gastrointestinal
;
IL-2
;
interleukin 2
;
IM
;
intramuscular
;
MedDRA
;
Medical Dictionary for Regulatory Activities
;
MS
;
multiple sclerosis
;
RRMS
;
relapsing-remitting multiple sclerosis
;
SAE
;
serious adverse event
;
SMQ
;
Standardised
MedDRA
Query
;
SOC
;
System Organ Class
;
ULN
;
upper li
刊名:Multiple Sclerosis and Related Disorders
出版年:2016
3.
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
作者:
Kiyotaka Yoh
;
MD
a
;
kyoh@east.ncc.go.jp" class="auth_mail" title="E-mail the corresponding author
;
Yukio Hosomi
;
MD PhD
b
;
Kazuo Kasahara
;
MD PhD
c
;
Kazuhiko Yamada
;
MD PhD
d
;
Toshiaki Takahashi
;
MD
e
;
Nobuyuki Yamamoto
;
MD PhD
f
;
Makoto Nishio
;
MD PhD
g
;
Yuichiro Ohe
;
MD PhD
h
;
Toshiko Koue
;
PhD
i
;
Takashi Nakamura
;
MPH
i
;
Sotaro Enatsu
;
MD PhD
i
;
Pablo Lee
;
MD
j
;
David Ferry
;
PhD
j
;
Tomohide Tamura
;
MD
k
;
Kazuhiko Nakagawa
;
MD PhD
l
关键词:
AE
;
adverse event
;
CI
;
confidence interval
;
CR
;
complete response
;
CT
;
computed tomography
;
DCR
;
disease control rate
;
ECOG
;
Eastern Cooperative Oncology Group
;
EGFR
;
epidermal growth factor receptor
;
FAS
;
full analysis set
;
HR
;
hazard ratio
;
ILD
;
interstitial lung disease
;
IRRC
;
Independent Response Review Committee
;
MedDRA
;
medical dictionary for regulatory activities
;
MRI
;
magnetic resonance imaging
;
NCI-CTCAE
;
national cancer institute-common terminology criteria for adverse events
;
NSCLC
;
n
刊名:Lung Cancer
出版年:2016
4.
Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis
作者:
Takahiko Saida
a
;
Saida_takahiko@maia.eonet.ne.jp" class="auth_mail" title="E-mail the corresponding author
;
Jun-ichi Kira
b
;
kira@neuro.med.kyushu-u.ac.jp" class="auth_mail" title="E-mail the corresponding author
;
Yasuhiro Ueno
c
;
yasuhiro.ueno@biogen.com" class="auth_mail" title="E-mail the corresponding author
;
Naozumi Harada
c
;
nysharad@gmail.com" class="auth_mail" title="E-mail the corresponding author
;
Toshiyuki Hirakata
c
;
toshiyuki.hirakata@biogen.com" class="auth_mail" title="E-mail the corresponding author
关键词:
ARR
;
annualized relapse rate
;
CI
;
confidence interval
;
EDSS
;
Expanded Disability Status Scores
;
Gd+
;
gadolinium-enhancing
;
IFN beta
;
interferon beta
;
IFN beta-1a
;
interferon beta-1a
;
IM
;
intramuscular
;
MedDRA
;
Medical Dictionary for Regulatory Activities
;
MRI
;
magnetic resonance imaging
;
MS
;
multiple sclerosis
;
MSCRG
;
Multiple Sclerosis Collaborative Research Group
;
RRMS
;
relapsing remitting multiple sclerosis
;
SD
;
standard deviation
刊名:Multiple Sclerosis and Related Disorders
出版年:2016
5.
OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval
作者:
Julien Souvignet
a
;
b
;
c
;
d
;
Gunnar Declerck
e
;
Hadyl Asfari
a
;
b
;
c
;
Marie-Christine Jaulent
a
;
b
;
c
;
Cé
;
dric Bousquet
a
;
b
;
c
;
d
;
cedric.bousquet@chu-st-etienne.fr" class="auth_mail" title="E-mail the corresponding author
关键词:
Knowledge representation
;
Pharmacovigilance
;
Biological ontologies
;
Terminological reasoning
;
Data retrieval
刊名:Journal of Biomedical Informatics
出版年:2016
6.
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
作者:
Thomas K. Eigentler
a
;
1
;
thomas.eigentler@med.uni-tuebingen.de" class="auth_mail" title="E-mail the corresponding author
;
Jessica C. Hassel
b
;
1
;
jessica.hassel@med.uni-heidelberg.de" class="auth_mail" title="E-mail the corresponding author
;
Carola Berking
c
;
carola.berking@med.uni-muenchen.de" class="auth_mail" title="E-mail the corresponding author
;
Jens Aberle
d
;
aberle@uke.de" class="auth_mail" title="E-mail the corresponding author
;
Oliver Bachmann
e
;
bachmann.oliver@mh-hannover.de" class="auth_mail" title="E-mail the corresponding author
;
Viktor Grü
;
nwald
f
;
Gruenwald.Victor@mh-hannover.de" class="auth_mail" title="E-mail the corresponding author
;
Katharina C. Kä
;
hler
g
;
kckaehler@dermatology.uni-kiel.de" class="auth_mail" title="E-mail the corresponding author
;
Carmen Loquai
h
;
Carmen.Loquai@unimedizin-mainz.de" class="auth_mail" title="E-mail the corresponding author
;
Niels Reinmuth
i
;
n.reinmuth@lungenclinic.de" class="auth_mail" title="E-mail the corresponding author
;
Martin Steins
j
;
martin.steins@med.uni-heidelberg.de" class="auth_mail" title="E-mail the corresponding author
;
Lisa Zimmer
k
;
lisa.zimmer@uk-essen.de" class="auth_mail" title="E-mail the corresponding author
;
Anna Sendl
l
;
anna.sendl@bms.com" class="auth_mail" title="E-mail the corresponding author
;
Ralf Gutzmer
m
;
gutzmer.ralf@mh-hannover.de" class="auth_mail" title="E-mail the corresponding author
关键词:
Immunotherapy
;
PD-1
;
Nivolumab
;
Pembrolizumab
;
Adverse drug reaction
;
Immune-related adverse events
刊名:Cancer Treatment Reviews
出版年:2016
7.
Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance
作者:
Amneet Sandhu
a
;
b
;
David Kao
a
;
Philip S. Mehler
b
;
Mark C.P. Haigney
c
;
Mori J. Krantz
a
;
b
;
mkrantz@dhha.org" class="auth_mail" title="E-mail the corresponding author
关键词:
Naloxone
;
Cardiovascular disorders
刊名:International Journal of Cardiology
出版年:2016
8.
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
作者:
E. Raschi
a
;
E. Poluzzi
a
;
A. Koci
a
;
I.C. Antonazzo
a
;
G. Marchesini
b
;
F. De Ponti
a
;
fabrizio.deponti@unibo.it" class="auth_mail" title="E-mail the corresponding author
关键词:
Dipeptidyl peptidase-4 inhibitors
;
Sitagliptin
;
Saxagliptin
;
Heart failure
;
Drug safety
;
Disproportionality
;
Spontaneous reporting system
;
FAERS
刊名:Nutrition, Metabolism and Cardiovascular Diseases
出版年:2016
9.
Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer
作者:
Karim Fizazi
a
;
karim.fizazi@igr.fr" class="auth_mail" title="E-mail the corresponding author
;
Kim N. Chi
b
;
Johann S. de Bono
c
;
Leonard G. Gomella
d
;
Kurt Miller
e
;
Dana E. Rathkopf
f
;
Charles J. Ryan
g
;
Howard I. Scher
f
;
Neal D. Shore
h
;
Peter De Porre
i
;
Anil Londhe
j
;
Tracy McGowan
k
;
Nonko Pelhivanov
l
;
Robert Charnas
m
;
Mary B. Todd
n
;
Bruce Montgomery
o
关键词:
Abiraterone acetate
;
Adverse events
;
Corticosteroids
;
Glucocorticoid
;
Long term
;
Metastatic castration-resistant prostate cancer
;
Tolerability
刊名:European Urology
出版年:2016
10.
Formalizing
MedDRA
to support semantic reasoning on adverse drug reaction terms
作者:
Cé
;
dric Bousquet
a
;
b
;
É
;
ric Sadou
a
;
Julien Souvignet
a
;
b
;
Marie-Christine Jaulent
a
;
Gunnar Declerck
a
;
gunnar.declerck@upmc.fr" class="auth_mail
关键词:
MedDRA
;
SNOMED-CT
;
Ontology
;
Terminology
;
Semantic reasoning
;
Adverse drug reaction
刊名:Journal of Biomedical Informatics
出版年:June 2014
1
2
3
4
5
6
按检索点细分(50)
题名(6)
关键词(21)
文摘(34)
按出版年细分(50)
2027年及以后(6)
2017年(1)
2016年(8)
2015年(3)
2013年(6)
2012年(5)
2011年(2)
2010年(4)
2009年(2)
2008年(2)
2007年(3)
2006年(3)
2005年(2)
2002年(1)
2000年(1)
2000年及以前(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.